Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
OBN
OBN
Activities:
Media
Research & Development
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
New recruits at OBN
Bill Fleming and David Browning join board of the not-for-profit membership organisation supporting UK's life sciences companies, corporate partners and investors
Research & Development
BioForward - The 'Roadmap for Growth' Life Sciences Event
4 October 2018 | Conference | Birmingham, UK
OBN appoints three new directors
New members add considerable sector experience to the board, bringing legal, investment, commercial and general management expertise
Research & Development
Biotrinity 2016
25 - 27 April 2016, Conference, Novotel London West, London, UK
Research & Development
ABPI and OBN sign Memorandum of Understanding
To look for partnership initiatives to help build better public profile and understanding of all biosciences
OBN strengthens Board and Operations team
UK membership organisation has about 260 members
Research & Development
BioTrinity
12 - 14 May 2014, Conference, Novotel London West, UK
Subscribe now